Search in:

Advanced search

Patient Preference and Adherence Volume 11, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

John F Foley1 Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT, USA

Kavita V Nair2 Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO, USA

Timothy Vollmer3 Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA

Judith J Stephenson4 HealthCore, Inc., Wilmington, DE, USA

Timothy Niecko5 Niecko Health Economics, Tierra Verde, FL, USA

Sonalee S Agarwal6 Biogen, Cambridge, MA, USA

Crystal Watson6 Biogen, Cambridge, MA, USACorrespondence[email protected]

show all

Pages 1035-1048 | Published online: 16 Jun 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MiloREffectiveness of multiple sclerosis treatment with current immunomodulatory drugsExpert Opin Pharmacother201516565967325582634
PubMed Web of Science ®Google Scholar
MillerDMWeinstock-GuttmanBBourdetteDYouXFouldsPRudickRAChange in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon β-1aMult Scler201117673474221300736
PubMed Web of Science ®Google Scholar
ZwibelHLContribution of impaired mobility and general symptoms to the burden of multiple sclerosisAdv Ther200926121043105720082242
PubMed Web of Science ®Google Scholar
RiaziAHobartJCLampingDLUsing the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profilesJ Neurol Neurosurg Psychiatry200374671071412754336
PubMed Web of Science ®Google Scholar
RudickRAMillerDHassSHealth-related quality of life in multiple sclerosis: effects of natalizumabAnn Neurol200762433534617696126
PubMed Web of Science ®Google Scholar
RudickRAMillerDCloughJDGraggLAFarmerRGQuality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritisArch Neurol19924912123712421449401
PubMedGoogle Scholar
PolmanCHO’ConnorPWHavrdovaEA randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosisN Engl J Med2006354989991016510744
PubMed Web of Science ®Google Scholar
PhillipsJTGiovannoniGLublinFDSustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosisMult Scler201117897097921421809
PubMed Web of Science ®Google Scholar
StephensonJJKernDMAgarwalSSImpact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal studyHealth Qual Life Outcomes201210115523270428
PubMed Web of Science ®Google Scholar
MaruishMETurner-BowkerDMA Guide to the Development of Certified Modes of Short Form Survey AdministrationLincoln, RIQualityMetric Incorporated2009
Google Scholar
WareJKosinskiMTurner-BowkerDGandekBSF-12v2: How to Score Version 2 of the SF-12 Health SurveyLincoln, RIQuality Metric Incorporated2002
Google Scholar
NormanGRSloanJAWyrwichKWInterpretation of changes in health-related quality of life: the remarkable universality of half a standard deviationMed Care200341558259212719681
PubMed Web of Science ®Google Scholar
HobartJLampingDFitzpatrickRRiaziAThompsonAThe Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measureBrain2001124Pt 596297311335698
PubMed Web of Science ®Google Scholar
McGuiganCHutchinsonMThe multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measureJ Neurol Neurosurg Psychiatry200475226626914742602
PubMed Web of Science ®Google Scholar
AtkinsonMJKumarRCappelleriJCHassSLHierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumersValue Health20058Suppl 1S9S2416336491
PubMed Web of Science ®Google Scholar
AtkinsonMJSinhaAHassSLValidation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth Qual Life Outcomes200421214987333
PubMedGoogle Scholar
BharmalMPayneKAtkinsonMJDesrosiersMPMoriskyDEGemmenEValidation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medicationsHealth Qual Life Outcomes200973619397800
PubMed Web of Science ®Google Scholar
GoodinDSA questionnaire to assess neurological impairment in multiple sclerosisMult Scler1998454444519839306
PubMed Web of Science ®Google Scholar
HoholMJOravEJWeinerHLDisease steps in multiple sclerosis: a simple approach to evaluate disease progressionNeurology19954522512557854521
PubMed Web of Science ®Google Scholar
HoholMJOravEJWeinerHLDisease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progressionMult Scler19995534935410516779
PubMed Web of Science ®Google Scholar
KavaliunasAManouchehriniaAStawiarzLImportance of early treatment initiation in the clinical course of multiple sclerosisMult Scler Epub102016
Google Scholar
ProsperiniLGianniCBarlettaVPredictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosisJ Neurol Sci20123231–210411223006974
PubMed Web of Science ®Google Scholar
ButzkuevenHKapposLPellegriniFEfficacy and safety of natalizumab in multiple sclerosis: interim observational programme resultsJ Neurol Neurosurg Psychiatry201485111190119724532785
PubMed Web of Science ®Google Scholar
GlanzBIMusallamARintellDJChitnisTWeinerHLHealyBCTreatment satisfaction in multiple sclerosisInt J MS Care2014162687525061430
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date